Michael Cookson, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Prokarium
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Nonagen Bioscience Corp.
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    MJH LifeSciences
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Health Publishing (Oncology)
    Ineligible company:
    BioPharm Communications
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Pfizer
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Meeting Participant or Lecturer (Oncology)
    Ineligible company:
    Clinical Education Alliance, LLC
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Pacifice Edge Diagnostics
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    TesoRx Pharma LLC
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Bayer Healthcare Pharmaceuticals
    Date added:
    Date updated:
    11/05/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Myovant Sciences
    Date added:
    Date updated:
    11/05/2024

Pages

Return to The Evolving Landscape of Advanced Prostate Cancer Treatment: A Guidelines and Case-Based Discussion Webcast (2022)